|
DDX19A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.06939999966471E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.5118999998125E-07 |
| Normal-vs-Stage2 |
1.784230E-02 |
| Normal-vs-Stage3 |
1.43560000553933E-08 |
| Normal-vs-Stage4 |
1.3132999999721E-06 |
| Stage1-vs-Stage2 |
1.328990E-01 |
| Stage1-vs-Stage3 |
6.520300E-02 |
| Stage1-vs-Stage4 |
3.259800E-01 |
| Stage2-vs-Stage3 |
1.249560E-02 |
| Stage2-vs-Stage4 |
5.978000E-02 |
| Stage3-vs-Stage4 |
6.927600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.38640000035828E-07 |
| Normal-vs-AfricanAmerican |
4.616000E-02 |
| Normal-vs-Asian |
5.66140000000104E-05 |
| Caucasian-vs-AfricanAmerican |
1.313030E-01 |
| Caucasian-vs-Asian |
8.770800E-01 |
| AfricanAmerican-vs-Asian |
2.008800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.00969999028422E-09 |
| Normal-vs-Female |
2.5984000000534E-06 |
| Male-vs-Female |
1.191570E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.97329999995777E-06 |
| Normal-vs-Age(41-60Yrs) |
1.1188999999856E-06 |
| Normal-vs-Age(61-80Yrs) |
1.36200000000475E-06 |
| Normal-vs-Age(81-100Yrs) |
2.775400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.290000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.789800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.437400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.815400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.326400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.881000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.811900E-02 |
| Classical-VS-Follicular |
1.770640E-01 |
| Classical-VS-Other |
3.220200E-02 |
| Classical-VS-Normal |
2.65710000002528E-06 |
| Tall-VS-Follicular |
4.657600E-01 |
| Tall-VS-Other |
2.237600E-01 |
| Tall-VS-Normal |
1.65630000004136E-06 |
| Follicular-VS-Other |
2.306800E-01 |
| Follicular-VS-Normal |
4.54400000005073E-06 |
| Other-VS-Normal |
2.354300E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.71189999995403E-06 |
| Normal-vs-N1 |
1.16709999997688E-07 |
| N0-vs-N1 |
3.679800E-02 |
|
|
